Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Mulhearnet al-Reference-Cited by-同舟云学术

Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Mulhearnet al

Published:2021-03-01 Issue: Volume: Page:annrheumdis-2021-220134
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Schäfer Martin,Strangfeld Anja^ORCID,Hyrich Kimme L^ORCID,Carmona Loreto^ORCID,Gianfrancesco Milena,Lawson-Tovey Saskia,Mateus Elsa F,Gossec Laure^ORCID,Robinson Philip C^ORCID,Yazdany Jinoos,Machado Pedro M^ORCID

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference6 articles.

1. Mulhearn B . Correspondence on “Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry”. Ann Rheum Dis 2021.doi:10.1136/annrheumdis-2021-220099

2. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 global rheumatology alliance physician-reported registry;Strangfeld;Ann Rheum Dis,2021

3. Confounding by Indication in Clinical Research

4. Glucocorticoids in rheumatoid arthritis: current status and future studies

5. EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of a cognitive-behavioral digital therapeutic on psychosocial outcomes in rheumatoid arthritis: randomized controlled trial;npj Mental Health Research;2024-09-03

2. Association of immunomodulatory therapies with COVID-19 mortality in rheumatoid arthritis: An analysis of the FDA adverse event reporting system;Intelligent Pharmacy;2024-08

3. COVID-19 in patients with rheumatic diseases: frequency and course;Medical alphabet;2024-07-21

4. Pandemic of the century: COVID-19 in inflammatory rheumatic diseases of a national cohort with 3,532 patients;Archives of Rheumatology;2024-03-22

5. Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects;Rheumatology Science and Practice;2024-02-29